Related coverage linked through entity extraction aliases.
Feb 13, 2026
A matched analysis of 923 men found salvage focal therapy and radical prostatectomy achieved comparable 10-year cancer-specific survival for prostate cancer recurring after radiotherapy, though surgery carried significantly higher complication rates.
Feb 13, 2026
Novartis debuted its "Relax, it's a blood test" prostate cancer awareness initiative at Super Bowl LX with an experiential booth and commercial featuring NFL tight ends, ranking seventh among all ads.
Mar 28, 2025
Radiopharmaceuticals are emerging as a promising therapeutic class in oncology, with theranostic approaches combining diagnostics and treatment gaining particular attention. Major pharmaceutical companies have invested billions in acquisitions while venture financing reached record levels.
Dec 22, 2025
The FDA approved multiple denosumab biosimilars in late 2025 and issued REMS safety updates emphasizing severe hypocalcemia risk in patients with advanced chronic kidney disease, including reported hospitalizations and fatalities.
